TERI L. LAWVER
GLOBAL COMMERCIAL STRATEGY LEADER
Teri Lawver is the Global Commercial Strategy Leader, Global Vice President, for the Immunology Therapeutic Area with Janssen Pharmaceutical Companies of Johnson & Johnson. Together with the Immunology R&D Therapeutic Area leader, she has end-to-end responsibility for the Janssen Immunology portfolio and pipeline.
Teri has more than 25 years of global healthcare and business leadership experience spanning three continents, three healthcare sectors, and dozens of disease areas. Since joining Johnson & Johnson in 2002 at Centocor, Teri has held several leadership and executive positions across the Johnson & Johnson Family of Companies. She is a values-driven leader who has delivered above-market performance in each of the five Johnson & Johnson business units she has led. Prior to joining Johnson & Johnson, Teri was an Associate Principal at McKinsey & Company and a leader in the Firm’s Global Healthcare practice. She began her career as a Derivatives Analyst at Bloomberg Financial Markets, LLP.
A multi-faceted leader, Teri is adept at delivering both transformational strategies and operational excellence. She is a vocal champion of diversity and inclusion, and has a proven track record of building new businesses, creating sustainable innovation-based growth, identifying exceptional talent, and developing high-performance teams.
Teri holds a Bachelor of Science degree, summa cum laude, from Georgetown University in Washington D.C., and an MBA from Duke University in Durham, North Carolina.